Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems

Marta Trevisan, Alessandro Sinigaglia, Giovanna Desole, Alessandro Berto, Monia Pacenti, Giorgio Palù, Luisa Barzon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The recent biotechnology breakthrough of cell reprogramming and generation of nduced pluripotent stem cells (iPSCs), which has revolutionized the approaches to study he mechanisms of human diseases and to test new drugs, can be exploited to generate atient-specific models for the investigation of host–pathogen interactions and to develop ew antimicrobial and antiviral therapies. Applications of iPSC technology to the study f viral infections in humans have included in vitro modeling of viral infections of neural, iver, and cardiac cells; modeling of human genetic susceptibility to severe viral infectious iseases, such as encephalitis and severe influenza; genetic engineering and genome editing f patient-specific iPSC-derived cells to confer antiviral resistance.

Original languageEnglish
Pages (from-to)3835-3856
Number of pages22
JournalViruses
Volume7
Issue number7
DOIs
Publication statusPublished - Jul 13 2015

Fingerprint

Induced Pluripotent Stem Cells
Virus Diseases
Antiviral Agents
Communicable Diseases
Pluripotent Stem Cells
Genetic Engineering
Medical Genetics
Encephalitis
Genetic Predisposition to Disease
Biotechnology
Human Influenza
Technology
Therapeutics
Pharmaceutical Preparations
In Vitro Techniques
Gene Editing
Cellular Reprogramming

Keywords

  • Antiviral resistance
  • CRISPR/Cas9
  • Ersonalized therapy
  • Genetic susceptibility
  • Genome editing
  • Hepatitis C virus
  • Human immunodeficiency virus
  • Human induced pluripotent stem cells
  • Patient-specific isease model
  • Viral infection

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Trevisan, M., Sinigaglia, A., Desole, G., Berto, A., Pacenti, M., Palù, G., & Barzon, L. (2015). Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems. Viruses, 7(7), 3835-3856. https://doi.org/10.3390/v7072800

Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems. / Trevisan, Marta; Sinigaglia, Alessandro; Desole, Giovanna; Berto, Alessandro; Pacenti, Monia; Palù, Giorgio; Barzon, Luisa.

In: Viruses, Vol. 7, No. 7, 13.07.2015, p. 3835-3856.

Research output: Contribution to journalArticle

Trevisan, M, Sinigaglia, A, Desole, G, Berto, A, Pacenti, M, Palù, G & Barzon, L 2015, 'Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems', Viruses, vol. 7, no. 7, pp. 3835-3856. https://doi.org/10.3390/v7072800
Trevisan, Marta ; Sinigaglia, Alessandro ; Desole, Giovanna ; Berto, Alessandro ; Pacenti, Monia ; Palù, Giorgio ; Barzon, Luisa. / Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems. In: Viruses. 2015 ; Vol. 7, No. 7. pp. 3835-3856.
@article{82b4e3f6d6aa471c8d877b8015a9d940,
title = "Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems",
abstract = "The recent biotechnology breakthrough of cell reprogramming and generation of nduced pluripotent stem cells (iPSCs), which has revolutionized the approaches to study he mechanisms of human diseases and to test new drugs, can be exploited to generate atient-specific models for the investigation of host–pathogen interactions and to develop ew antimicrobial and antiviral therapies. Applications of iPSC technology to the study f viral infections in humans have included in vitro modeling of viral infections of neural, iver, and cardiac cells; modeling of human genetic susceptibility to severe viral infectious iseases, such as encephalitis and severe influenza; genetic engineering and genome editing f patient-specific iPSC-derived cells to confer antiviral resistance.",
keywords = "Antiviral resistance, CRISPR/Cas9, Ersonalized therapy, Genetic susceptibility, Genome editing, Hepatitis C virus, Human immunodeficiency virus, Human induced pluripotent stem cells, Patient-specific isease model, Viral infection",
author = "Marta Trevisan and Alessandro Sinigaglia and Giovanna Desole and Alessandro Berto and Monia Pacenti and Giorgio Pal{\`u} and Luisa Barzon",
year = "2015",
month = "7",
day = "13",
doi = "10.3390/v7072800",
language = "English",
volume = "7",
pages = "3835--3856",
journal = "Viruses",
issn = "1999-4915",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",

}

TY - JOUR

T1 - Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems

AU - Trevisan, Marta

AU - Sinigaglia, Alessandro

AU - Desole, Giovanna

AU - Berto, Alessandro

AU - Pacenti, Monia

AU - Palù, Giorgio

AU - Barzon, Luisa

PY - 2015/7/13

Y1 - 2015/7/13

N2 - The recent biotechnology breakthrough of cell reprogramming and generation of nduced pluripotent stem cells (iPSCs), which has revolutionized the approaches to study he mechanisms of human diseases and to test new drugs, can be exploited to generate atient-specific models for the investigation of host–pathogen interactions and to develop ew antimicrobial and antiviral therapies. Applications of iPSC technology to the study f viral infections in humans have included in vitro modeling of viral infections of neural, iver, and cardiac cells; modeling of human genetic susceptibility to severe viral infectious iseases, such as encephalitis and severe influenza; genetic engineering and genome editing f patient-specific iPSC-derived cells to confer antiviral resistance.

AB - The recent biotechnology breakthrough of cell reprogramming and generation of nduced pluripotent stem cells (iPSCs), which has revolutionized the approaches to study he mechanisms of human diseases and to test new drugs, can be exploited to generate atient-specific models for the investigation of host–pathogen interactions and to develop ew antimicrobial and antiviral therapies. Applications of iPSC technology to the study f viral infections in humans have included in vitro modeling of viral infections of neural, iver, and cardiac cells; modeling of human genetic susceptibility to severe viral infectious iseases, such as encephalitis and severe influenza; genetic engineering and genome editing f patient-specific iPSC-derived cells to confer antiviral resistance.

KW - Antiviral resistance

KW - CRISPR/Cas9

KW - Ersonalized therapy

KW - Genetic susceptibility

KW - Genome editing

KW - Hepatitis C virus

KW - Human immunodeficiency virus

KW - Human induced pluripotent stem cells

KW - Patient-specific isease model

KW - Viral infection

UR - http://www.scopus.com/inward/record.url?scp=84937510370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937510370&partnerID=8YFLogxK

U2 - 10.3390/v7072800

DO - 10.3390/v7072800

M3 - Article

VL - 7

SP - 3835

EP - 3856

JO - Viruses

JF - Viruses

SN - 1999-4915

IS - 7

ER -